Beta-3-adrenergic Receptor rs4994 Polymorphism Is a Potential Biomarker for the Development of Nonalcoholic Fatty Liver Disease in Overweight/Obese Individuals

Table 7

The clinical characteristics of the samples using by 5,000 randomly sampled data sets.

	ADRB3 rs4994 genotype
	T/T ()	T/C ()	C/C ()	value
Age (years)	66 (17–97)	65 (20–93)	66 (34–91)	0.41
BMI (kg/m^2)	22.8 (14.1–35.2)	22.8 (14.5–33.7)	22.9 (14.6–32.9)	0.96
Diabetes (%)	13.4	13.4	10.5	0.49^†
Dyslipidemia (%)	55.8	60.1	48.1	< 0.01^†
NAFLD (%)	18.1	22.5	28.6	< 0.01^†

Data are the median (range) or proportion for categorical variables. ADRB3: beta-3-adrenergic receptor; BMI: body mass index; NAFLD: nonalcoholic fatty liver disease. ^†Analyzed by Fisher’s exact test, otherwise Kruskal Wallis test.